• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Catheter ablation more effective than antiarrythmic escalation for ventricular tachycardia: The VANISH trial

byJames RoebkerandShaidah Deghan, MSc. MD
July 13, 2016
in Cardiology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Catheter ablation was found to be more effective than escalated antiarrhythmic drug (AAD) therapy at treating patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD) who had ventricular tachycardia (VT) despite AAD therapy.

2. The increased effectiveness was only observed in patients treated with amiodarone at baseline.

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Despite the effectiveness of ICDs at stopping VT secondary to myocardial infarction (MI), recurrent shocks carry health risks and these patients often require AAD therapy to suppress inducible ventricular tissue. When both fail to suppress VT, escalation of AAD therapy or catheter ablation is used. This study compared the efficacy of these two treatment options. The results demonstrated that the primary outcome of death at any time, refractory VT (defined as three or more episodes within 24 hours), or appropriate ICD shock within 30 days of treatment was significantly lower in the catheter ablation group as compared with the AAD escalation group. The significance of the primary outcome was largely due to a reduction in refractory VT and appropriate ICD shocks. However, this difference was only observed in patients receiving amiodarone at baseline. No difference was found using other AAD medications.

This study was randomized and conducted at tertiary centers where catheter ablation was routinely performed. All outcome measures and treatments used current clinical standards. Due to the type of therapy, however, the treating physicians could not be fully blinded to treatment arms.

Click to read the study, published today in NEJM

Relevant Reading: Prophylactic catheter ablation for the prevention of defibrillator therapy

RELATED REPORTS

Early initiation of rhythm-control for atrial fibrillation associated with lower risk of adverse cardiovascular outcomes

#VisualAbstract: Efficacy and safety of landiolol for treatment of sepsis-related tachyarrhythmia

Landiolol effective at controlling heart rate in sepsis related tachyarrhythmias

In-Depth [randomized controlled trial]: This randomized controlled trial enrolled 259 patients (132 assigned to undergo catheter ablation and 127 to escalated AAD therapy) with a previous MI, subsequent placement of an ICD, and had experienced VT within 6 months of treatment with a class I or III AAD. Other outcomes included the factors contributing to the primary outcome. Patients in the escalated-therapy group were treated with amiodarone +/- mexiletine.

The overall primary outcome, was significantly reduced in the ablation group compared to escalation of AAD therapy (HR 0.72; 95%CI 0.53 to 0.98; p = 0.04). However, this difference was only observed in patients treated with amiodarone at baseline (HR 0.55, 95%CI 0.38 to 0.80; p = 0.001) but not in patients treated with other AADs (p = 0.64). Additionally, there was no significant difference in individual components of the primary outcome: death during the trial (HR 0.96; 95%CI 0.60 to 1.53; p = 0.86), VT storm (HR 0.66; 95%CI 0.42 to 1.05; p = 0.08), and appropriate ICD shocks (HR 0.77; 95%CI 0.53 to 1.14; p = 0.19). Sustained VT below ICD detection at any time (HR 0.27; 95%CI 0.09 to 0.84; p = 0.02) and total number of these events (p = 0.02) were significantly reduced in the ablation group. Among adverse events, hepatic dysfunction (6 vs. 0 patients, p = 0.001), tremor or ataxia (6 vs. 0 patients, p = 0.01), and drug side effects (6 vs. 0 patients, p = 0.01) were significantly more common in the escalation therapy group.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anti-arrhythmictachyarrhythmias
Previous Post

President Obama reflects on the Affordable Care Act

Next Post

Gender conformity influences use of laxatives and muscle-building products

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Early initiation of rhythm-control for atrial fibrillation associated with lower risk of adverse cardiovascular outcomes

June 4, 2021
#VisualAbstract: Efficacy and safety of landiolol for treatment of sepsis-related tachyarrhythmia
StudyGraphics

#VisualAbstract: Efficacy and safety of landiolol for treatment of sepsis-related tachyarrhythmia

May 14, 2020
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Landiolol effective at controlling heart rate in sepsis related tachyarrhythmias

April 13, 2020
Cardiology

Vasopressin plus catecholamines lowers risk of atrial fibrillation in distributive shock

May 9, 2018
Next Post
Gender conformity influences use of laxatives and muscle-building products

Gender conformity influences use of laxatives and muscle-building products

Corticosteroids improve outcomes in treatment of community-acquired pneumonia

No mortality difference between early and delayed renal replacement therapy: The AKIKI trial

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Olanzapine may reduce nausea symptoms for patients on chemotherapy

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • LI-RADS outlines standards for liver imaging studies assessing HCC [Classics Series]
  • Daily disposable contact lenses may lower risk for Acanthamoeba keratitis
  • Vitamin D deficiency may be associated with sleep disorders in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.